Single-Port Laparoscopic Surgery for Inflammatory Bowel Disease

Table 1

Perioperative results of SPLS ileoc resection-right hemicolectomy for Crohn’s disease: included studies. Crohn-specific data were given wherever possible.

Author, year

Study; type

Total; number; of SPLS; patients

Disease (𝑛, all SPLS patients)

SPLS ileocecal resection-Right hemicolectomy (Crohn/; total)

Elective: emergency

Final incision length (cm)

Ileocolic anastomosis

Additional; trocars; (𝑛/cases)

Conversion; to open; surgery

Operative; time; (min)

Mortality; (𝑛/cases)

Morbidity; (𝑛/cases)

Reoperations; (𝑛/cases)

Hospital stay; (𝑑)

Read; missions; (𝑛/cases)

Adair et al.,; 2010 [29]

CC

17

CD: 1 Carcinoma: 11; Adenoma: 4 Other: 1

1/17

n.s.

3.8^*§

Extracorporeal

2/17*

0/17*

139 ± 29.7^*, §

1/17* (pulmonary embolism*)

4/17 (wound infection: 1,; Ileus 2, delayed thermal bowel injury: 1)

n.s.

3.9±3.7^§

n.s.

Heeney et al.,; 2010 [31]

CR

1

CD: 1

1/1

1 : 0

2.5

Extracorporeal

0/1

0/1

86

0/1

0/1

0/1

n.s.

0/1

Kawahara et al.,; 2010 [14]

CR

1

CD: 1

1/1

1 : 0

4.0

Extracorporeal

0/1

0/1

130

0/1

0/1

0/1

10

n.s.

Keshava et al.,; 2010 [33]

CS

22

CD: 1 Carcinoma: 13 Adenoma: 5 Other: 3

1/22

21 : 1*

4.0^*, #

Extracorporeal

0/22

0/22

105^*, #

0/22

5/22 (wound infection: 1,; ileus: 3, bleeding: 1)

2/22*

5^#

n.s.

Champagne et al.,; 2011 [12]

CC

29

CD: 7 Carcinoma: 12; Adenoma: 4 Diverticulitis: 6

*/19

7 : 0

3.8*

Extracorporeal

1/7

0/7

134^*, $

0/29

5/29* (n.s.)

0/29

3.7*

n.s.

Chaudhary et al.,; 2011 [34]

CC

4

CD: 4

4/4

n.s.

n.s.

n.s.

n.s.

1/4

n.s.

n.s.

n.s.

n.s.

n.s.

n.s.

Gaujoux et al.,; 2011 [32]

CS

13

CD: 3 Adenoma: 5 Diverticulitis: 3 Other: 2

2/6

n.s.

3.7

Extracorporeal

0/2

0/2

155^§

0/2

0/2

0/2

5^§

n.s.

Gaujoux et al.,; 2012 [11]

CC

25

CD: 6 UC: 2 Carcinoma: 3 Adenoma: 8 Diverticulitis: 4 Other: 2

*/13

24 : 1^$

n.s.

Extracorporeal

1/25*

0/6

130^*#

0/6

1/25*; (acute; urine; retention)

0/6

6^#

0/6

Gash et al.,; 2011 [17]

CS

20

CD: 4 UC: 3 Carcinoma: 8 Diverticulitis: 2 Other: 3

3/6

4 : 0

n.s.

n.s.

0/4

0/4

123^§

0/4

5/20* (wound infection: 1,; ileus: 2, anastomotic bleeding: 1,; other: 1)

0/4

5.2^§

1/20*

Geisler and Garrett,; 2011 [8]

CS

102

CD: 14 UC: 51 Neoplasia: 23 Diverticulitis: 11 Other: 3

*/26

14 : 0

4.4*

Extracorporeal

18/102*

1/102*

77*

0/102*

39/102* (wound infection: 11,; ileus: 12,; pulmonary: 10,; other: 6

0/26*

5.9*

0/26*

Karahasanoglu et al.,; 2011 [21]

CR

1

CD: 1

1/1

1 : 0

2.5

Intracorporeal

0/1

0/1

140

0/1

0/1

0/1

4

n.s.

Lee et al.,; 2011 [9]

CC

46

CD: 5 Neoplasia: 25 Diverticulitis: 16

*/24

n.s.

5.1*

Extracorporeal

2/24*

0/24*

122*

0/24

11/46* (wound infection: 4, anastomotic leak: 1, bleeding: 1, ileus: 1, other: 4

n.s.

4.6*

n.s.

Papaconstantinou et al.,; 2011 [15]

CC

29

CD: 2 Carcinoma: 15; Adenoma: 12

2/29

n.s.

4.5^§

Extracorporeal

0/29*

0/29*

129^*§

0/29*

6/29* (wound infection: 5, anastomotic leak: 1)

1/29*

3.4^§

4/29*

Ross et al.,; 2011 [10]

CS

39

CD: 5 Carcinoma: 15; Adenoma: 12 Divertculitis: 7

*/30

n.s.

4.2^§

n.s.

3/39*

0/5

120*

0/5

3/39* (wound infection: 1, bleeding: 2)

0/5

4.4*

0/5

Scaringi et al.,; 2011 [22]

CR

1

CD: 1

1/1

1 : 0

n.s.

Extracorporeal

0/1

0/1

115

0/1

0/1

n.s.

5

n.s.

Stewart and Messaris,; 2012 [27]

CS

41

CD: 7 UC: 6 Carcinoma: 11; Adenoma: 4 Diverticultis: 10 Other: 3

4/13

29 : 12*

3.2*

Extracorporeal

1/7

5/41*

178^*$

0/7

7/35* (anastomotic leak: 1, intraabd. abscess: 1, other: 5)

1/41

8.7^*§

5/35*

Vestweber et al.,; 2011 [20]

CS

200

CD: 21 UC: 16 Diverticulitis: 120 Other: 43

21/26

200 : 0*

n.s.

Extracorporeal

n.s.^$

n.s.^§

n.s.^§

0/200*

n.s.^§

n.s.^§

9*

n.s.

Wolthuis et al.,; 2011 [23]

CC

14

CD: 6 Carcinoma: 5 Adenoma: 1 Diverticulitis: 2

5/10

14 : 0

5*

Extracorporeal

0/6

0/6

75^#*

0/5

0/5

1/5

7^#*

0/6

Champagne et al.,; 2012 [13]

CC

165

CD: 26 UC: 13 Carcinoma: 64; Adenoma: 41 Diverticulitis: 15 Other: 6

*/117

n.s.

n.s.

n.s.

14/165*

n.s.

135^*§

1/165*

42/165* (wound infection: 7, ileus: 15, delayed thermal injury: 1, bleeding: 1, cardiovascular: 4, other: 15

2/165*

4.3^*§

8/165*

Rijcken et al.,; 2012 [16]

CC

20

CD: 20

20/20

20 : 0

3.8^§

Extracorporeal

0/20

1/20

137^§

0/20

4/20 (wound infection: 2, anastomotic leak: 1, intraabd. abscess: 1)

1/20

9^§

1/20

Stewart and Messaris,; 2012 [35]

CS

6

CD: 6

6/6

n.s.

3.5^§

Extracorporeal

1/6

0/6

160^§

0/6

2/6 (wound infection: 1, intraabd. abscess: 1)

0/6

4.8^§

0/6

Waters et al.,; 2012 [36]

CS

100

CD: 5 Carcinoma: 57 Adenoma: 5

5/100

95 : 5

3.5^§*

Extracorporeal

2/100*

4/100*

114^§*

1/100* (bleeding)

14/100* (wound infection: 4, ileus: 4, bleeding: 3,; anastomotic leak/; abscess: 2, other: 1)

1/100*

5*

n.s.

*Not particularly specified for Crohn’s disease
^$Not specified for SPLS ileocecal resection-right hemicolectomy
^§Mean value, ^#median value
n.s.: not specified
CC: case-controlled study, CR: case report, CS: case series
CD: Crohn’s disease, UC: ulcerative colitis.